013 - Obesity Guidelines and Weight Loss Pharmacotherapy
In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/helixtalk\/013_-_Obesity_Guidelines_and_Pharmacotherapy.mp3?dest-id=187168","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202310\/51d8ce-5810-087d-300941_800.png"},"title":"013 - Obesity Guidelines and Weight Loss Pharmacotherapy","link":"javascript:;","id":"item-685492"}]
